SINOBAY Biotech and Tofflon Life Science have entered a strategic partnership to drive forward innovations in cell therapy! This collaboration focuses on developing advanced CAR-T, CAR-NK, and CAR-NKT...
Advancing Together
Lipid nanoparticles (LNPs)
Vaccine Bioprocessing Collection
ElementalImpurities
Influenza Vaccine Manufacturing
What is AAV Vectors?
FDA 21 CFR Part 11 and EU Annex 11
Tofflon Team (Fred Wu, David Luo, Way Wen, Anna Yakhutina, Irina Galushko, Elmira Amineva, Max Yin) had participated in the 7th International Scientific Practical Conference
Unlocking the Potential of CHO Cells for Bioprocessing Chinese hamster ovary (CHO) cells have become the foremost platform for manufacturing therapeutic antibodies and proteins.
Unleash the power of research with Tofflon Life Science
China Chamber of Commerce for Import and Export of Machinery and Electronic Products (CCCME)
Bioreactors and Serum-Free Medium Vaccine development and manufacturing have experienced tremendous growth in recent decades.
A system designed to support the development of genomic drugs. Its microfluidic technology enables controlled encapsulation and delivery of nanomedicines like lipid nanoparticles (LNPs) and polymer nanoparticles (PNPs).
HAPPY NEW YEAR
Exciting News!
